Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SCPH
    4. >
  4. Valuation

Valuation

-
stocks logo
SCPH
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is SCPH Overvalued？

SCPH is now in the zone, suggesting that SCPH current forward PE ratio of -2.60 is considered compare with the five-year average of -4.39.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

SCPH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SCPH.O
scPharmaceuticals Inc
loss
Average P/E:
-86.94%
164.13M
stocks logo
RAPT.O
RAPT Therapeutics Inc
loss
Average P/E:
42.07%
150.49M
stocks logo
GNLX.O
Genelux Corp
loss
Average P/E:
8.17%
144.37M
stocks logo
ADCT.N
ADC Therapeutics SA
loss
Average P/E:
170.17M
stocks logo
THRD.O
Third Harmonic Bio Inc
loss
Average P/E:
-80.51%
155.45M
stocks logo
ENTA.O
Enanta Pharmaceuticals Inc
loss
Average P/E:
33.75%
165.97M

SCPH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

SCPH FAQs

Is SCPH currently overvalued based on its P/E ratio?

According to the provided data, SCPH's 5-year historical average forward P/E ratio is -4.39. SCPH forward P/E ratio is -2.60, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for SCPH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SCPH's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 7.03 to 6.15, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SCPH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

SCPH PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-4.39
Current PE
-2.60
Overvalued PE
-3.20
Undervalued PE
-5.58

SCPH EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
-2.92
Current EV
-2.67
Overvalued EV
-1.26
Undervalued EV
-4.57

SCPH P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
20.19
Current PS
2.50
Overvalued PS
51.61
Undervalued PS
-11.23

SCPH Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
SCPH.O
scPharmaceuticals Inc
loss
Average P/E:
-86.94%
164.13M
stocks logo
RAPT.O
RAPT Therapeutics Inc
loss
Average P/E:
42.07%
150.49M
stocks logo
GNLX.O
Genelux Corp
loss
Average P/E:
8.17%
144.37M
stocks logo
ADCT.N
ADC Therapeutics SA
loss
Average P/E:
170.17M
stocks logo
THRD.O
Third Harmonic Bio Inc
loss
Average P/E:
-80.51%
155.45M
stocks logo
ENTA.O
Enanta Pharmaceuticals Inc
loss
Average P/E:
33.75%
165.97M

SCPH Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SCPH undervalued？Is SCPH overvalued compared to its competitors？

SCPH FAQs

Is SCPH currently overvalued based on its P/E ratio?

According to the provided data, SCPH's 5-year historical average forward P/E ratio is -4.39. SCPH forward P/E ratio is -2.60, which is categorized as Overvalued.

What is the significance of the EV/EBITDA ratio for SCPH?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has SCPH's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 7.03 to 6.15, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for SCPH's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is SCPH undervalued？Is SCPH overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free